Insider · CIK 0001520181
Mary C Beckerle
Files at EXEL (EXELIXIS, INC.), HUN (Huntsman CORP). First filing Nov 8, 2024, latest Feb 19, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
EXEL: EXELIXIS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
HUN: Huntsman CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | EXELIXIS, INC. | $426k 12,210 shares | -29% | +38% from low · -6% from high | |
| 52Moderate | HUNsell Huntsman CORP | $433k 20,201 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | EXEL EXELIXIS, INC. | MOption exercise Common Stock | +8,354 | $23.24 | $194k | 42,616 | Feb 19, 2025 |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock | -8,354 | $34.87 | $291k | 34,262 | Feb 19, 2025 |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | SOpen-market sale Common Stock | -3,856 | $34.90 | $135k | 30,406 | Feb 19, 2025 |
| Feb 14, 2025 | EXEL EXELIXIS, INC. | MOption exercise Option (right to buy)derivative | -8,354 | $0.00 | $0 | 22,494 | Feb 19, 2025 |
| Feb 13, 2025 | HUN Huntsman CORP | AGrant or award Common Stock | +9,717 | $0.00 | $0 | 9,717 | Feb 18, 2025 |
| Nov 6, 2024 | HUN Huntsman CORP | SOpen-market sale Common Stock | -20,201 | $21.42 | $433k | 0 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.